Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II1, diffuse large B-cell lymphoma of the stomach

Cancer Science

Volumn 96, Issue 6, 2005, Pages 349-352

  Ishikura, Satoshi ^a   Tobinai, Kensei ^b   Ohtsu, Atsushi ^a   Nakamura, Shigeo ^d   Yoshino, Tadashi ^e   Oda, Ichiro ^b   Takagi, Toshiyuki ^f   Mera, Kiyomi ^a   Kagami, Yoshikazu ^b   Itoh, Kuniaki ^a   Tamaki, Yoshio ^g   Suzumiya, Junji ^h   Taniwaki, Masafumi ⁱ   Yamamoto, Seiichiro ^c  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f CHIBA CANCER CENTER   (Japan)

^g GUNMA PREFECTURAL CANCER CENTER   (Japan)

^h FUKUOKA UNIVERSITY   (Japan)

ⁱ KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GASTRECTOMY; HUMAN; JAPAN; LARGE CELL LYMPHOMA; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; STOMACH FUNCTION; STOMACH HEMORRHAGE; STOMACH LYMPHOMA; STOMACH PERFORATION; STOMACH PROTECTION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; GASTRECTOMY; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 22444450763     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00051.x     Document Type: Article

References (22)

1. Wotherspoon AC. A critical review of the effect of [i#Helicobacter pylori#1i] eradication on gastric MALT lymphoma. [i#Curr Gastroenterol Rep#1i] 2000; [b#2#1b]: 494-8.
2. Bozzetti F, Audisio RA, Giardini R [i#et al.#1i] Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: an old problem revisited. [i#Br J Surg#1i] 1993; [b#80#1b]: 1101-6.
3. Ruskone-Fourmestraux A, Aegerter P, Delmer A [i#et al.#1i] Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. [i#Gastroenterology#1i] 1993; [b#105#1b]: 1662-71.
4. Bartlett DL, Karpeh MS, Jr, Filippa DA [i#et al.#1i] Long-term follow-up after curative surgery for early gastric lymphoma. [i#Ann Surg#1i] 1996; [b#223#1b]: 53-62.
5. Vaillant JC, Ruskone-Fourmestraux A, Aegerter P [i#et al.#1i] Management and long-term results of surgery for localized gastric lymphomas. [i#Am J Surg#1i] 2000; [b#179#1b]: 216-22.
6. Binn M, Ruskone-Fourmestraux A, Lepage E [i#et al.#1i] Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. [i#Ann Oncol#1i] 2003; [b#14#1b]: 1751-7.
7. Koch P, del Valle F, Berdel WE [i#et al.#1i] Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma - results of the prospective German Multicenter Study GIT NHL 01/92. [i#J Clin Oncol#1i] 2001; [b#15#1b]: 3874-83.
8. Brincker H, D'Amore F. A retrospective analysis of treatment outcome in 106 cases of localized gastric non-Hodgkin lymphomas. Danish Lymphoma Study Group, LYFO. [i#Leuk Lymphoma#1i] 1995; [b#18#1b]: 281-8.
9. Raderer M, Valencak J, Osterreicher C [i#et al.#1i] Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE. [i#Cancer#1i] 2000; [b#88#1b]: 1979-85.
10. Maor MH, Velasquez WS, Fuller LM [i#et al.#1i] Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. [i#J Clin Oncol#1i] 1990; [b#8#1b]: 266-71.
11. Miller TP, Dahlberg S, Cassady JR [i#et al.#1i] Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. [i#N Engl J Med#1i] 1998; [b#339#1b]: 21-6.
12. Rohatiner A, d'Amore F, Coiffier B [i#et al.#1i] Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. [i#Ann Oncol#1i] 1994; [b#5#1b]: 397-400.
13. Cheson BD, Horning SJ, Coiffier B [i#et al.#1i] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. [i#J Clin Oncol#1i] 1999; [b#17#1b]: 1244-53.
14. Banno S, Yoshikawa K, Nakamura S [i#et al.#1i] Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus. [i#Jpn J Cancer Res#1i] 1994; [b#85#1b]: 918-26.
15. Schwarz RJ, Conners JM, Schmidt N. Diagnosis and management of stage IE and stage IIE gastric lymphoma. [i#Am J Surg#1i] 1993; [b#165#1b]: 561-5.
16. Maisey N, Norman A, Prior Y [i#et al.#1i] Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications? [i#Clin Oncol#1i] 2004; [b#16#1b]: 48-52.
17. Fujishima H, Misawa T, Maruoka A [i#et al.#1i] Staging and follow-up of primary gastric lymphoma by endoscopic ultrasonography. [i#Am J Gastroenterol#1i] 1991; [b#86#1b]: 719-24.
18. Palazzo L, Roseau G, Ruskone-Fourmestraux A [i#et al.#1i] Endoscopic ultrasonography in the local staging of primary gastric lymphoma. [i#Endoscopy#1i] 1993; [b#25#1b]: 502-8.
19. Coiffier B, Lepage E, Briere J [i#et al.#1i] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [i#N Engl J Med#1i] 2002; [b#346#1b]: 235-42.
20. Pfreundschuh MG, Trumper L, Ma D [i#et al.#1i] Randomized intergroup trial of first line treatment for patients ≤ 60 years with diffuse large B-cell non-Hodgkin's lymphoma. (DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab - early stopping after the first interim analysis. [i#Proc Am Soc Clin Oncol#1i] 2004; [b#23#1b]: 556a. (Abstract 6500).
21. Wohrer S, Puspok A, Drach J [i#et al.#1i] Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. [i#Ann Oncol#1i] 2004; [b#15#1b]: 1086-90.
22. Maor MH, North LB, Cabanillas FF [i#et al.#1i] Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. [i#Int J Radiat Oncol Biol Phys#1i] 1998; [b#41#1b]: 647-50.